PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
7545489-4	1995	Our results show that G-CSF was able to maintain the proliferative activity of BM cells in the presence of ceftazidime if it was added to the culture medium during the early phase of exposure of BM to ceftazidime.	Ceftazidime	107-118	colony stimulating factor 3	Homo sapiens	22-27	
17599307-3	2007	METHODS: In this randomized, placebo-controlled trial, we assessed the efficacy of lenograstim (granulocyte colony-stimulating factor [G-CSF], 263 mu g per day administered intravenously) in ceftazidime-treated patients with severe sepsis caused by suspected melioidosis in Thailand.	Ceftazidime	191-202	colony stimulating factor 3	Homo sapiens	96-133	
7545489-0	1995	Role of granulocyte colony-stimulating factor in preventing ceftazidime-induced myelosuppression in vitro.	Ceftazidime	60-71	colony stimulating factor 3	Homo sapiens	8-45	
7545489-3	1995	The present study was carried out to define the role of G-CSF in preventing the ceftazidime-induced suppression of BM progenitor cells in vitro, and to define the mechanisms involved in ceftazidime-induced myelosuppression.	Ceftazidime	80-91	colony stimulating factor 3	Homo sapiens	56-61	
7545489-4	1995	Our results show that G-CSF was able to maintain the proliferative activity of BM cells in the presence of ceftazidime if it was added to the culture medium during the early phase of exposure of BM to ceftazidime.	Ceftazidime	201-212	colony stimulating factor 3	Homo sapiens	22-27	
7545489-8	1995	These data suggest that G-CSF prevents the ceftazidime-induced myelosuppression by antagonizing the suppressive effect of TNF and by enhancing the proliferative activity of BM.	Ceftazidime	43-54	colony stimulating factor 3	Homo sapiens	24-29